Production (Stage)
Labcorp Holdings Inc.
LH
$242.53
$0.640.27%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 3.35B | 3.33B | 3.28B | 3.22B | 3.18B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 3.35B | 3.33B | 3.28B | 3.22B | 3.18B |
| Cost of Revenue | 2.40B | 2.43B | 2.38B | 2.29B | 2.28B |
| Gross Profit | 948.00M | 896.30M | 904.40M | 926.40M | 897.30M |
| SG&A Expenses | 546.00M | 595.20M | 568.60M | 557.80M | 508.40M |
| Depreciation & Amortization | 69.60M | 70.40M | 63.70M | 62.20M | 60.10M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.01B | 3.10B | 3.01B | 2.91B | 2.85B |
| Operating Income | 332.40M | 230.70M | 272.10M | 306.40M | 328.80M |
| Income Before Tax | 275.20M | 183.80M | 210.60M | 267.70M | 297.40M |
| Income Tax Expenses | 62.20M | 40.20M | 41.00M | 62.10M | 69.10M |
| Earnings from Continuing Operations | 213.00M | 143.60M | 169.60M | 205.60M | 228.30M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -200.00K | -200.00K | -300.00K | -300.00K | -300.00K |
| Net Income | 212.80M | 143.40M | 169.30M | 205.30M | 228.00M |
| EBIT | 332.40M | 230.70M | 272.10M | 306.40M | 328.80M |
| EBITDA | 499.20M | 321.20M | 433.60M | 463.30M | 483.30M |
| EPS Basic | 2.55 | 1.72 | 2.02 | 2.44 | 2.71 |
| Normalized Basic EPS | 2.10 | 1.79 | 1.74 | 2.25 | 2.23 |
| EPS Diluted | 2.52 | 1.71 | 2.00 | 2.43 | 2.69 |
| Normalized Diluted EPS | 2.09 | 1.78 | 1.73 | 2.25 | 2.21 |
| Average Basic Shares Outstanding | 83.60M | 83.60M | 84.00M | 84.10M | 84.10M |
| Average Diluted Shares Outstanding | 84.30M | 84.20M | 84.40M | 84.30M | 84.70M |
| Dividend Per Share | 0.72 | 0.72 | 0.72 | 0.72 | 0.72 |
| Payout Ratio | 28.95% | 41.91% | 35.74% | 29.42% | 27.24% |